PRFX
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- PRF Technologies reports PRF-110 showed sustained 72-hour pain relief in preclinical comparison studyMay 26, 2026
- PRF Technologies received FDA clearance of its IND application for the OcuRing-K Phase II clinical trialApr 28, 2026
- PainReform Ltd. completes strategic investment in LayerBio to enter $9B global cataract surgery market with breakthrough non-opiate, non-steroidal postoperative NSAID drug delivery systemAug 13, 2025